When you seek cancer care at Guthrie Robert Packer Hospital, a Commission on Cancer-accredited cancer center, you are gaining access to comprehensive, state-of-the-art cancer care close to home.
Why is CoC Accreditation Important?
The CoC Accreditation Program provides the framework for Guthrie to improve its quality of patient care throughout the full spectrum of cancer care including:
- Early diagnosis
- Cancer staging
- Optimal treatment
- Life-long follow-up for recurrent disease
- End-of-life care
CoC accreditation ensures that these key elements of quality cancer care are provided to each person treated within Guthrie’s cancer program:
- Comprehensive, patient-centered care through a multidisciplinary team approach
- Access to information on clinical trials and new treatment options
- Ongoing monitoring of care and lifelong patient follow-up
- Psycho-social support and survivorship care
- Continuous quality improvements in patient care
How long has Guthrie’s program been accredited?
The cancer care program at Guthrie Robert Packer Hospital has been accredited with the Commission on Cancer since 1938. In 2018, we celebrate 80 years and are proud of the continuous work by our cancer team to provide the best patient-centered care possible. The team’s voluntary commitment to providing high quality, patient-centered care is at the core of our program at all facilities – Sayre, Corning and Wellsboro.
About the Commission on Cancer
The Commission on Cancer (CoC) is a quality program of the American College of Surgeons (ACS). It is a consortium of professional organizations dedicated to improving survival and quality of life of patients with cancer through standards setting, prevention, research, education, and the monitoring of comprehensive care.
To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care.
CoC-accredited facilities diagnose and/or treat more than 70 percent of all newly diagnosed patients with cancer.